Stay updated with breaking news from Nasdaq Cdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 3,550,000 shares, a growth of 63.6% from the March 15th total of 2,170,000 shares. Based on an average daily volume of 3,570,000 shares, the […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 3,550,000 shares, a growth of 63.6% from the March 15th total of 2,170,000 shares. Based on an average daily volume of 3,570,000 shares, the […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 3,550,000 shares, a growth of 63.6% from the March 15th total of 2,170,000 shares. Based on an average daily volume of 3,570,000 shares, the […]
Cidara Therapeutics (NASDAQ:CDTX – Get Rating) and Cullinan Oncology (NASDAQ:CGEM – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Analyst Recommendations This is a breakdown of current ratings […]
Jeppson Wealth Management LLC trimmed its stake in shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) by 7.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 160,610 shares of the biotechnology company’s stock after selling 13,565 shares […]